Concepedia

Sonia Maciejewski

SM

23

Publications

1.5K

Citations

17

H-Index

2009

Active since

Affiliations

Novavax (United States)(Current)

University of Maryland, Baltimore

Baylor College of Medicine

National Institute of Allergy and Infectious Diseases

Ragon Institute of MGH, MIT and Harvard

Sonia Maciejewski is an author at Novavax (United States) specializing in immunology, medicine, and vaccine development.

ORCID

Top concepts

Publications per year

2009–2023

23

Publications

23

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Jing-Hui Tian, Nita Patel, Robert Haupt et al. · Nature Communications · 2021 · 517 citations · Full text

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

Mimi Guebre‐Xabier, Nita Patel, Jing-Hui Tian et al. · Vaccine · 2020 · 238 citations · Full text

, , +14

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination

Matthew J. Gorman, Nita Patel, Mimi Guebre‐Xabier et al. · Cell Reports Medicine · 2021 · 144 citations · Full text

, , +7

Viral Persistence and Chronic Immunopathology in the Adult Central Nervous System following Coxsackievirus Infection during the Neonatal Period

Ralph Feuer, Chelsea M. Ruller, Naili An et al. · Journal of Virology · 2009 · 83 citations · Full text

Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial

Raburn M. Mallory, Neil Formica, Susan Pfeiffer et al. · The Lancet Infectious Diseases · 2022 · 78 citations · Full text

, , +7

Rows per page

1–5 of 23